Drugs
?
-
Peramivir Information
-
-
-
Historical Information
The information previously contained on these pages were authorized under the 2009 H1N1 Influenza Emergency Use Authorizations (EUAs).As of June 23, 2010, the EUA authorizing the use of the unapproved drug peramivir has been terminated and will no longer be in effect. The following historical information is no longer current.
Information for Healthcare Professionals: Peramivir IV Renal Dosing Recommendations Questions and Answers for Health Care Providers: Renal Dosing and Administration Recommendations for Peramivir IV (PDF - 114KB)Peramivir IV Questions and Answers for Health Care Providers FDA Authorizes Emergency Use of Intravenous Antiviral Peramivir for 2009 H1N1 Influenza for Certain Patients, Settings Peramivir Letter for Emergency Use Authorization (PDF - 65KB)Peramivir Patient Fact Sheet (PDF - 35KB)Peramivir Fact Sheet for Health Care Providers (PDF - 381KB)Information for Healthcare Professionals - Mandatory Adverse Event Reporting for Emergency Use of Peramivir IV Under EUA Issued 10/23/2009
-
Contact FDA
1-800-332-1088
1-800-FDA-0178 Fax
Report a Serious Problem
Regular Mail: Use postage-paid FDA Form 3500
Mail to: MedWatch 5600 Fishers Lane
Rockville, MD 20857
-
-